Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Multiple drugs

Various toxicities, lack of efficacy and off-label use: 10 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Jimenez M, et al. Real-world data with the use of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura: A single-center with homogeneous treatment experience. Transfusion 62 : 2363-2369, No. 11, Nov 2022. Available from: URL: http://doi.org/10.1111/trf.17111 Jimenez M, et al. Real-world data with the use of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura: A single-center with homogeneous treatment experience. Transfusion 62 : 2363-2369, No. 11, Nov 2022. Available from: URL: http://​doi.​org/​10.​1111/​trf.​17111
Metadaten
Titel
Multiple drugs
Various toxicities, lack of efficacy and off-label use: 10 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41978-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antifungals

Case report

Imatinib

Case report

Prednisolone